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Abstract
Bioelectrics is a new interdisciplinary field that investigates electric field effects on cell membranes and other
cellular components. It incorporates four main technologies, including electroporation, nanosecond pulsed electric
fields, picosecond pulsed electric fields and cold plasmas. The parent technology in Bioelectrics is electroporation,
which uses milli- and/or micro-second electric pulses to permeabilize cells and tissues, for delivery of membrane
impermeable molecules. It is now being used for electro-gene delivery, with vascular endothelial growth factor, for
revascularization in wound healing and cardiovascular and peripheral vascular disease. Plasmids expressing IL-12 are
being delivered for immune system activation in melanoma treatment, now in phase II clinical trials. DNA vaccine delivery
by electroporation is also being investigated. More recently, electroporation has been extended to include nanosecond
pulsed electric fields (nsPEFs), a pulse power technology that was originally designed for military applications. It stores
intense levels of electric energy, and then unleashes nanosecond bursts of instantaneous power into cells and tissues,
creating unique intracellular conditions of high power and low, non-thermal energy. It is presently being used for cancer
ablation of skin and internal tumors, and for platelet activation for wound healing in injury and diabetes. An extension
of nsPEFs is to make the pulses even shorter, using picosecond pulsed electric fields. This is being developed as an
imaging system to detect cancer and other aberrant tissues, using an antenna. The fourth technology is cold plasmas
or ionized gasses, a fourth state of matter. Applications of these ionized gases are being developed for decontaminating
wounds, water, food and surfaces. Other possible applications that are of specific interest, but not yet fully investigated,
and/or developed, are pain control, fat ablation and decontamination of indwelling catheters. This review will outline
some applications of Bioelectrics, with greatest focus on nsPEF effects on cells in vitro and tumors in vivo.

Keywords: Electroporation; Nanosecond pulsed electric fields;
Cancer ablation; Apoptosis

A New Interdisciplinary Field In Bioelectrics
Bioelectrics is a burgeoning new interdisciplinary field, unifying
an interdisciplinary team of scientists who integrate knowledge of
electrical principles and theory, modeling and simulations, physics,
material sciences, molecular cell biology, animal sciences and medicine.
It investigates interactions of electric fields with cells and tissues for
a number of possible basic science and therapeutic applications.
There are also possible environmental applications. Bioelectrics was
initially realized, but not specifically defined or named, when it was
found that microsecond electric field effects on plasma membranes
enhanced the penetration of DNA into mouse L-cells developing
stable transformants [1]. This electric field mediated DNA transfer
was called electroporation, and a model was proposed that electric
field interactions with lipid dipoles in a pore configuration enhanced
transport across the plasma membrane. More recently, pulse power
technology, which originally was used for military purposes, has been
applied to cells and tissues. This has led to some new and innovative
possibilities for a number of potential uses. Of specific interest is to
determine the nature of electric field interactions with cell membranes
and other cellular structures, to determine how these effects alter cell
functions, and to determine how Bioelectrics can be applied for basic
science and medical advantages.

Applications of bioelectrics
Ageneral overview of uses for Bioelectrics includes applications
that deliver DNA to cells and tissues, transiently or permanently alter
cell membranes and other cell constituents, modulate cell signaling
mechanisms, disinfect and decontaminate. Therapeutic applications
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include treating cancer [2-7], coronary and peripheral vascular disease
[8]; activating platelets to enhance wound healing [9]; modulating
cardiomyocyte action potentials [10]; transfecting plasmids for protein
expression to improve wound healing [11], and to enhance immune
responses [12]; vaccinating against diseases [13]; possibly imaging
malignancies [14], and controlling pain by blocking nerve conduction
[15]. Other applications include using electric fields [16,17] and cold
plasmas [18], for sterilizing liquids, foods and surfaces; purifying air
and water [19], and removing oxides of nitrogen and sulfur from diesel
exhaust [20]. Another new field emerging in Bioelectrics is plasma
medicine, where room temperature atmospheric pressure plasmas are
used for sterilization, hygiene and dental/medical applications [21].
In this review, a major focus will be on applying milli-, microand nano-second pulsed electric fields (nsPEFs) in basic science and
medicine. Most space will be filled on efficacy and mechanisms of
cancer ablation with nsPEFs, in vitro and in vivo. For topics of materials
sciences and engineering, the emphasis is to analyze interactions
of electric field waveforms with biological materials, including cell
membranes and other cellular components for medical applications.
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Electroporation for Drug and Gene Delivery
As indicated above, the most notable and recognized application
of Bioelectrics is the use of external electric fields on biological cells
to permeabilize cell membranes by electroporation [1]. In practice,
electroporation is used to deliver impermeable molecules, such
as nucleic acids, drugs or other molecules obstructed by plasma
membranes. With potential problems for DNA delivery by viruses,
delivery of plasmids or other nucleic acids to cells and tissues by
electroporation has been shown to be safe and effective in humans
[12]. It was also shown that only minor histological changes occurred
in electroporated muscle [22], with neither little or no changes in gene
profiles for major tumor suppressor genes or oncogenes of the cell
cycle, nor change in expression of genes involved in DNA stability [23].
One practical medical application for electroporation is to permeabilize
tumor cell membranes for the delivery of poorly permeable drugs,
such as bleomycin, in a procedure called electrochemotherapy (ECT).
Although not generally used in the US, ECT is now widely and
successfully used in Europe for the treatment of cancer [24]

Electrogene therapy for cancer treatment
Use of the C57Bl/6 mouse harboring B16F10 melanoma tumors
demonstrated feasibility for therapeutic applications of electro-gene
therapy (EGT) to treat tumors. Initial thoughts were to use EGT for
replacing defective genes. However, a major focus has been on several
basic strategies for cancer therapy, including immune potentiation,
suicide gene therapy, restoration of tumor suppressor genes,
inhibition of oncogenes, anti-angiogenic gene therapy, delivering
genes encoding toxins, or siRNAs to knockdown proteins important
for survival and growth [25-27]. The delivery of a plasmid for IL-12
to metastatic melanoma tumors showed safety, efficacy reproducibility
and titratability in Phase I clinical trials [12]. 42% of melanoma
patients who had no other approved treatment options showed disease
stabilization or partial responses. In addition, 2 of 19 patients with
non-electroporated distant lesions and no other systemic therapy
showed complete regression of all metastases. Phase II clinical trials are
ongoing. In pre-clinical trials [28], EGT utilizing a plasmid encoding
for vascular endothelial growth factor (VEGF) demonstrated that
wound healing could be accelerated [11]. Other studies found that high
antibody titers after electroporation delivery of a plasmid encoding
Hepatitis B surface antigen could be achieved after two applications
[13].

Electrogene therapy for cardiovascular disease
EGT has also been shown to be effective in vivo to ischemic swine
hearts, as a potential therapeutic approach for treatment of heart
diseases [8]. Using three different penetrating electrodes and one
non-penetrating electrode, the authors have shown that gene transfer
to ischemic hearts via electroporation can be a safe and effective,
non-viral method for delivering genes in vivo. Eight electric pulses
of various widths and field strengths were synchronized to the rising
phase of R waves of electrocardiograms, following an injection of
either a plasmid encoding luciferase, or one encoding green fluorescent
protein. Four different sites on the anterior wall of the left ventricle
were treated. Expression was significantly higher in all electroporated
sites, when compared to sites with plasmid injection only. It will now
be interesting to determine if therapeutic genes such as VEGF can be
effectively delivered to hearts after myocardial infarction, and if the
expressed gene can improve cardiac function following an ischemic
event.
J Nanomed Nanotechol
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Cell survival and DNA delivery during electroporation of course
EGT requires that cells survive electroporation treatment, so they can
express the gene of interest. Thus, there is a threshold transmembrane
voltage that establishes permeabilization, another threshold that
optiwmizes gene delivery and minimizes cell death; however, this
condition may or may not be the condition that optimizes gene
expression. Finally, there is a threshold that completely compromises
cell viability, such that cells are irreversibly permeabilized [1,29-31].
Using this technique of Irreversible Electroporation (IRE) [32], is now
in clinical trials for liver cancer treatment.
Exactly how electric fields affect cell membranes and other
cellular mechanisms is still not completely understood. The term
electroporation implies that “pores” or “aqueous channels” are formed
in plasma membranes. This is consistent with transport of ions across
membranes, as determined by a number of methods, including
molecular dynamic simulations [33,34] and patch clamp studies [35],
among others. However, it is unlikely that DNA diffuses into cells
through these so-called pores. There is general agreement that the
primary role in pore formation is played by water dipoles as they create
water defects, and as they increasingly interact with electric fields at the
lipid-water interface; initial steps in pore formation do not depend on
the nature of lipid headgroups [33,34]. A number of steps are required
for DNA entry into cells: electrophoretic migration of DNA towards
the cell, DNA insertion into the membrane, translocation across
the membrane, migration of DNA towards the nucleus, and finally
transfer of DNA across the nuclear envelope [29,35-37]. Continuing
investigations now suggest that these electric fields affect endocytotic
mechanisms, engulfing DNA in membrane bound vesicles [38-40].
While this may account for how DNA gets into cells, it remains to
be determined how DNA is released from these vesicles, enters the
nucleus, and is engaged for gene transcription.

Pulse Power Technology And Nanosecond Pulsed
Electric Fields (nsPEFs)
Comprehending pulse power
All electric methods discussed above use millisecond or microsecond
pulses and relatively low electric fields. For ECT and EGT, electric field
strengths are in the range of V/cm; however, IRE electric fields are
generally in the low kV/cm range. A more recent approach is to make
greater use of pulse power technology by shortening pulse durations
into the nanosecond domain, and increasing electric field strengths
into the range of tens or hundreds of kV/cm [41-43]. By storing electric
energy in capacitors and releasing it in sub-microsecond bursts, electric
fields can be delivered to cells and tissues with unique qualities of high
peak power and low energy. When pulse repetition rates are relatively
low, effects are non-thermal. The power is high because it is released
in nanosecond durations. An example of pulse power principles is to
compare storage of one joule of energy released in one second versus
releasing the same energy in one microsecond or one nanosecond. If
the stored joule of energy is released all at once in one second, the peak
power delivered would only be 1 watt. If all of the stored energy were
released within one microsecond, the power would be one megawatt,
a million times greater; if released in one nanosecond, the peak power
would be one gigawatt, a billion times greater. This is enough power to
light a medium sized city for that nanosecond.

Perceiving the nanosecond time domain
To conceptualize nanoseconds, consider that the blink of an eye
takes about 0.2 seconds or 200 milliseconds (ms). So, 60 ms would be
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about one quarter of the blink of an eye, or a very quick blink. Then,
60 nanoseconds would be 1/4000 of the blink of an eye. Another
comparison is to consider the distance that light travels in a given
amount of time. Light travels 300 million meters/sec, or about 0.3
meters/ns, or about 1 foot. For pulse durations used in studies discussed
here, often 60-100 ns, light would travel about 20-30 yards; the distance
for 2 or 3 first downs on a football field. Of specific interests here are the
consequences of these nanosecond bursts, and the interactions of these
intense electric fields with cell and tissue structures, and ultimately,
with cell and tissue functions.

Intracellular effects and nanoporation with nsPEFs
Unlike conventional electroporation pulses, nanosecond pulses
are hypothesized to affect intracellular membranes. Therefore, a
major focus has been on nsPEF effects on the endoplasmic reticulum,
other calcium stores, mitochondria, and/or nuclei. The premise states
that pulses with short durations and rapid (short) pulse rise and fall
times charge intracellular membranes, which would have different
effects on cell structures, and functions compared to conventional
electroporation. When considering this pulse rise-fall principle in the
frequency domain instead of the time domain, these rise-fall times
would exhibit transient high frequency components, which affect
intracellular membranes [44,45]. The initial concept of nsPEF effects
was that plasma membranes were not affected or less affected. In
experiments with cells in vitro, calcein did not escape from intracellular
vesicles into the cytoplasm [41], and propidium iodide (PI) did not
initially enter cells [42,46], suggesting that plasma membranes remained
intact. Later it became clear that breaches in plasma membranes were
too small to allow escape or admission of molecules with sizes larger
than about a nanometer, slighter smaller than calcein and PI. Modeling
results showed nsPEF-induced conditions of supra-electroporation or
formation of high density nanopores in all cell membranes [47,48],
which were later demonstrated experimentally. Experimental results
demonstrated that cell membranes were depolarized and ions smaller
than calcein and PI, such as TI [49] and Ca2+ [45] crossed plasma
membranes under certain conditions, without transport of these
larger molecules. Plasma membranes were depolarized and membrane
potentials approached zero after cells were exposed to nsPEFs [50].
When nsPEFs were shown to eliminate cancer cells, evidence was
interpreted as markers for apoptosis [2,51,52] and necrosis [50]. Such
mechanisms could generally result from effects on plasma membranes,
intracellular membranes, or both.

In Vitro Evidence For Cell Death Mechanisms In
Response To nsPEFs
Extrinsic or intrinsic cell death?
It was hypothesized that nsPEF-induced apoptosis resulted from
supra-electroporation [48]. Again, this could be due to extrinsic effects
on plasma membranes, or intrinsic effects on endoplasmic reticulum,
mitochondria and/or nuclei/DNA. Lysosomes could also be affecting,
but have not been analyzed. In vitro studies in B16f10 melanoma [53]
and E4 squamous cell carcinoma (SCC) [54] suggested that extrinsic
apoptosis was at least partly involved, and caspase-independent cell
death mechanisms were also implicated. For activation of an extrinsic
pathway, it was possible that nsPEF effects on plasma membranes
would aggregate Fas receptors. This would induce formation of the
death-induced signaling complex (DISC), which is composed of Fas
associated death domain (FADD), and inactive caspase-8 binding
to the intracellular domains of the Fas receptor. By this mechanism,
J Nanomed Nanotechol
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caspase-8 would be activated. Caspase-8 could then directly activate
caspase-3 (type I cells) or cleave Bid (type II cells), which would lead
to cytochrome c release, activation of caspase-9, and then, activation
of caspase-3.

Extrinsic cell death?
To test for extrinsic apoptotic cell death, wild type Jurkat clones
were compared to clones deficient in FADD (ΔFADD) or caspase-8
(Δcaspase-8) [55]. Caspase activities [-8,-9,-3] were increased in
electric field- and time-dependent manners in all clones. When these
clones were treated with ten 60 ns pulses with increasing electric fields
(0-60 kV/cm), there were no differences in electric field effects on cell
viability. All of these clones had electric field LD 50 values of about
30 kV/cm. However, it has been shown that nearly all cell types will
die when given lethal apoptotic stimuli, in the presence of caspase
inhibition with the pan caspase inhibitor z-VAD-fmk [56,57]. Thus, in
ΔFADD and Δcaspase-8 caspase experiments, this did not really rule
out an extrinsic apoptosis pathway in nsPEF treated cells. However,
it did show that like other apoptosis stimuli, nsPEFs activate similar
caspase-independent cell death mechanisms in the absence of caspase
activities.
To more specifically test for nsPEF-activated extrinsic apoptosis,
cells were analyzed for cytochrome c release in the presence of the pan
caspase inhibitor z-VAD-fmk. Under these conditions, if the extrinsic
pathway were activated, cytochrome c release would be decreased in
nsPEF-stimulated cells. However, results revealed that cytochrome c
release was not affected by lethal nsPEF conditions at times up to 6
hours after treatment [55]. This indicated that the extrinsic pathway,
and/or other pathways that may require FADD or caspase-8 were not
functional in Jurkat cells, in response to nsPEFs.

Intrinsic cell death
Having ruled out the extrinsic pathway, the intrinsic pathway was
tested using a Jurkat clone deficient in APAF-1 (ΔAPAF-1) [55]. APAF1 is required in the intrinsic pathway to form the apoptosome, including
a complex of APAF-1 with cytochrome c, d-ATP and caspase-9,
which activates caspase-9. Caspase-9, then, activates caspase-3. It was
shown that nsPEFs did not activate caspase-3 in ΔAPAF-1, but did
in the vector control and wild type clone [55]. When analyzing cell
viability, the vector control exhibited a linear electric-field dependent
decrease in viability for 0-60 kV/cm, with significant decreases in cell
viability at 20 kV/cm. In contrast, ΔAPAF-1 did not show significant
decreases in cell viability, until about 40 kV/cm. Between 50 and 60 kV/
cm, there were no differences in cell viability between the two clones.
These results demonstrated for the first time that nsPEF-induced cell
death was APAF-1- and caspase-dependent at lower electric fields,
but caspase-independent at higher electric fields. Thus, in Jurkat
cells, nsPEF-induced cell death occurred through intrinsic pathways
in the functional absence of extrinsic apoptosis involving FADD and
caspase-8.

NsPEF subcellular targets for cell death induction
Although type I and type II extrinsic pathways were not operative
in response to nsPEFs, roles for plasma membranes, intracellular
membranes, mitochondria and DNA/nuclei in cell death had not
been fully investigated. Release of calcium from the endoplasmic
reticulum (ER) previously had been shown as an intracellular effect
of nsPEFs [42,58]. In addition, nsPEFs were shown to dissipate the
mitochondria membrane potential (ΔΨm) [53,54,59,60]. To carry
these analyses further, it was of interest to determine how increases
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in intracellular calcium and loss of ΔΨm were involved in cell death.
N1-S1 hepatocellular carcinoma (HCC) cells we used [44,45], which
are used in an in vivo orthotopic HCC model in rats. Calcium release
from intracellular stores was not observed in N1-S1 cells, using Fluo4 as the calcium indicator. Since release of calcium from the ER
had been shown before [42,58], this suggested that calcium was not
released from intracellular stores in N1-S1 HCC cells, that Fluo-4 was
not sufficiently sensitive to detect it, or that increases in calcium were
transient and absent when they were analyzed in these studies 10-30
minutes after treatment. However, nsPEF-induced influx of calcium
through plasma membranes was readily evident, as was dissipation of
(ΔΨm). To determine roles for intracellular calcium and ΔΨm on cell
viability, the theory was directly tested that high frequency components
of nsPEFs (transient pulse features), which are determined by rapid
(short) rise and fall times of pulses, are important for maximizing
electric field interactions with intracellular membranes [44,45]. Here,
the intracellular effect was dissipation of ΔΨm. Using one 600 ns
pulse with fast (15 ns) and slow (150 ns) rise-fall times and increasing
electric fields, pulses with short rise-fall times had greater effects on
dissipation of ΔΨm, confirming the theory that transient pulse features
of nsPEFs were an important component for intracellular effects. In
addition, decreases in viability were parallel with dissipation of ΔΨm.
Moreover, under conditions of a slow rise-fall time and a mismatched
load, influx of Ca2+ was observed, but loss of ΔΨm and cell viability
were absent [45]. These findings indicated that loss in cell viability was
determined by dissipation of ΔΨm. However, effects on ΔΨm were
not readily observed in the absence of calcium, indicating that nsPEFinduced dissipation of ΔΨm was calcium-dependent. Given that most,
if not all, calcium-regulated responses are mediated by proteins, a

possible explanation for this finding is that effects of nsPEFs may be
on the mitochondria permeability transition pore, which is voltageand calcium-dependent [61]. This suggestion requires additional
experimentation.

A Model And Overview Of Subcellular Targets And Cell
Death Pathways Activated By nsPEFs In Vitro
Figure 1 shows a scheme of our present understanding of possible
subcellular targets and cell death mechanisms in response to nsPEFs,
and summarizes the finding presented above. The model is mostly
derived from experiments in human Jurkat cells. The dark green
elements and arrows show primary pathways and subcellular effects,
and the light green elements and arrows show secondary events that
are involved, as cells die in response to nsPEFs. The muted elements
do not appear to be operative in this model. Five possible primary
targets were considered for nsPEF-induced cell death. These included
aggregation of Fas receptors in plasma membranes [1], effects [2]
on plasma membrane poration, on intracellular Ca2+ stores [3,4] on
mitochondria, or on nuclei [5], and/or DNA.

Mitochondria and plasma membranes are nsPEF targets
Based on the evidence presented above and elsewhere [44,45,55],
mitochondria and the ΔΨm appear to be primary targets for nsPEFs;
cell death was correlated with loss of ΔΨm. With one nsPEF waveform,
cells responded with an influx of Ca2+, but without loss of ΔΨm and cell
viability. However, dissipation of ΔΨm did not occur in the absence of
calcium influx through plasma membranes. Thus, plasma membranes
were also targets for nsPEFs. The presence of nanopores in the plasma
membrane was observed when influx of Ca2+ could be seen at lower
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electric fields than influx of propidium iodide [44]. These data fit the
“two hit” hypothesis that requires a toxic stimulus, the nsPEF, as well as
the presence of high Ca2+, as two requirements for opening the mPTP
and disruption of ΔΨm [62,63]. Effects of nsPEFs on intracellular Ca2+
stores or on influx of Ca2+ alone were not sufficient for cell death in
N1-S1 cells, because release of intracellular Ca2+ or Ca2+ influx without
effects on ΔΨm did not lead to cell death [45].

Activation of the apoptosome
Thus, nsPEFs cause an influx of Ca2+, a decrease in ΔΨm,
especially with fast rise-fall times, release of cytochrome c [51,55] and
activation of caspase-9 and -3 [55]. This occurs through formation of
the apoptosome, clearly indicating activation of well-characterized,
intrinsic mitochondria-, APAF-1-mediated apoptosis pathway. In
addition, at high electric fields, nsPEF induced caspase-independent
cell death. Both caspase-dependent and –independent pathways most
likely originate due to effects on mitochondria in cells exhibiting
different fundamental cellular contexts.

Bid cleavage
In these studies, caspases appear to cleave Bid, but this does not
lead to cytochrome c release through the type II extrinsic pathway [55].
This must happen downstream of caspase-3 activation. The influx of
Ca2+ most likely also leads to activation of calpain [54], which cleaves
Bid, yet this does not seem to play a role in cytochrome c release
because cytochrome c release is not affected by calpain inhibitors [45].
It is anticipated that the impact of nsPEFs on mitochondria is sufficient
intense to exert maximum influence on cytochrome c release, leaving
little of no effect on t-Bid on that event.

DNA damage
Although DNA damage by double strand breaks was present in this
Jurkat cell model as determined by Histone 2AX phosphorylation, its
role in cell death has not yet been clearly determined. NsPEF-induced
DNA damage has been demonstrated in a number of cell types by a
number of assays in vitro [2,4,64,65], and in vivo [5,6]. In the Jurkat
model here, the presence of DNA double strand breaks did not induce
increases in Puma or Noxa, suggesting DNA damage was not a major
mechanism to activate intrinsic apoptosis in response to nsPEF [45].
While such damage could lead to cell death, cell death has not been
shown to be DNA damage-dependent. This is in contrast to cell death
that has been shown to be dependent on Ca2+ -influx, on dissipation of
ΔΨm, or on caspase activation shown here.

The Fas receptor is not involved
Aggregation or other possible mechanisms for activating Fas
receptors or the DISC do not appear to play a role in nsPEF-induced
cell death; cytochrome c release was not affected by inhibition of
caspases with z-VAD-fmk [55], which would be required if cell death
signals were initiated through formation of the DISC.

What causes the loss of ΔΨm?
Effects of nsPEFs have generally been considered to occur on
membranes, so the most likely possibility for dissipation of ΔΨm is
nanoporation of the inner mitochondria membrane, as suggested by
the supra-electroporation theorem [47,48]. Nevertheless, poration
of the plasma membrane is necessary, and the requirement for
Ca2+ for dissipation of ΔΨm appears to come from the extracellular
environment. However, poration is not expected to be Ca2+-dependent.
Under these considerations, the most likely event is an effect of
J Nanomed Nanotechol
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nsPEFs on a calcium- and/or voltage-dependent mechanism(s) of the
mitochondria permeability transition pore (mPTP) [61]. The rationale
for this conjecture is based on the requirement for Ca2+ for loss of
ΔΨm, and the evidence that most if not all effects of Ca2+ are mediated
through actions on proteins. The supposition of nsPEF effects on
proteins is unexpected and requires further study.

In Vivo Evidence For Mechanisms Of Cell Death And
Successful Ablation Of Tumors With nsPEFs
NsPEFs and cancer hallmarks
In tumor tissues, nsPEFs were first shown to reduce mouse B10.2
squamous cell carcinoma tumor size and induce apoptosis as shown
by TUNEL and activation of caspase catalytic activity [2,66]. They
also have been shown to eliminate mouse ectopic B16f10 tumors [35], ectopic mouse Hepa1-6 hepatocellular carcinoma [6], and murine
xenographs of human pancreatic carcinoma [67]. It was of specific
interest to determine mechanisms for tumor eradication based on rate
limiting–stochastic events involved with cancer growth and treatment.
A major complication in treating cancer is that it is really hundreds of
different diseases; even melanoma or liver cancer is often not a single
disease, not only among patients, but likely within the same patient.
For example, the recurrence of a treated cancer is often a different
cancer, even in the same organ [68]. Thus, cancers exhibit hundreds of
different genotypes defined by substantial numbers of mutations in a
wide variety of genes/proteins. In order to manage this array of diseases
and to provide more focused characterization of cancer, Hanahan and
Weinberg [69,70] defined eight major hallmarks of cancer that exhibit
physiological anomalies that control cell homeostasis and proliferation.
These include self-sufficiency in growth signals, insensitivity to
growth-inhibitory (antigrowth) signals, evasion of apoptosis, limitless
replicative potential, sustained angiogenesis, tissue invasion and
metastasis, reprogramming energy metabolism and evasion of immune
surveillance. In addition, genetic diversity of cancers is caused by an
unstable genome. Further, inflammation advances multiple cancer
hallmarks [70]. Considering these cancer hallmarks, it was relevant
to determine which of them were altered by nsPEFs. In two different
cancers, it has been shown that nsPEFs impinge upon multiple
hallmarks, and can thereby, mimic several different specific treatments.
For example, angiostatin and endostatin inhibit sustained angiogenesis;
vinblastine and vincristine affect limitless replicative potential.

Activation of caspase-associated and –unassociated cell death
by nsPEFs
In both B16f10 [5] and Hepa1-6 tumors [6], nsPEFs were shown
to induce apoptosis, as shown by activation of caspases, well-defined
indicators of apoptosis. The time course for activation of caspases-2, -6
and -7 mirrored cell shrinkage, decreases in nuclear size and nuclear
condensation. These characteristics were paralleled by DNA damage,
as indicated by TUNEL and histone 2AX phosphorylation; the latter is
specific for DNA double strand breaks. The coincidence of these makers
suggests that they were all part of the causes, and/or results of nsPEF
effects on cancer cells. However, these studies also showed that not all
cells exhibited active caspases after nsPEF treatment. This is consistent
with the in vitro E4 SCC [54] and Jurkat cell [55] studies mentioned
above, demonstrating both caspase-dependent and –independent cell
death.

Anti-angiogenesis/anti vascular effects with nsPEFs
Other evidence suggested that nsPEFs reversed sustained
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angiogenesis [5,6]. First, there was a decrease in vessel numbers
supplying tumors that was coincident with a decrease in tumor mass,
indicating an interruption of tumor-driven angiogenesis and tumor
blood supply. It could also be argued that there is an anti-vascular
effect. This was also shown by Doppler analysis of blood flow in murine
B16f10 melanoma [3]. Second, over a three week period after treatment
of nsPEFs, vascular endothelial growth factor (VEGF) progressively
decreased such that VEGF levels were one sixth the pre-treatment levels
[5,6]. VEGF is a requirement for the angiogenic switch that defines
homeostasis. This results in a loss of balance between stimulation and
inhibition of new blood vessel growth. The angiogenic switch defines an
early step for cancer metastasis and multistage carcinogenesis [69,70].
There were also decreases in platelet-derived endothelial cell growth
factor, a well-known chemotactic factor for vascular endothelial cells
and blood vessel formation. Moreover, effectors downstream of VEGF
were decreased, including three major microvascular density markers:
CD31, a platelet-endothelial cell adhesion molecule, used as a panendothelial cell marker; CD34, an endothelial cell marker and CD105,
a proliferation-related endothelial cell marker. Thus, while melanoma
and hepatocellular carcinoma tumors shrank and vessel numbers
were significantly reduced, formation of new vessels was extensively
inhibited.

DISC pathways, or otherwise interfere with caspase activation will still
die by caspase-independent mechanisms. Fifth, in addition to the antiangiogenesis effects of nsPEFs, they also have another advantage by
local infarction of small vessels, as shown by the decrease in blood vessel
numbers in the treatment zone [5]. Sixth, it can be argued that this
treatment also has an anti-vascular effect within the treatment zone. A
seventh advantage is the absence of local or systemic side effects by this
treatment. While the treatment does involve delivery of electric fields,
unpublished clinical trials indicated that injection of a local anesthetic,
such as lidocaine, nullifies any pain. Eighth, since pulses are so short,
there is for the most part, no muscle contraction as was shown when
normal pig liver was treated with nsPEFs [75]. However, when treating
ectopic tumors, it is important to prevent the electrode from coming
intact with muscle or nerves leading to them, and to have the animal
properly grounded during the treatment. Ninth, when electric fields
are sufficiently intense, all cells in the treatment zone can be killed,
including cancer stem cells and host cells that provide needed growth
factors for tumor growth and metastasis. Finally, confirmation of the
enhanced immune surveillance in humans after nsPEFs could provide
a highly significant advantage to nsPEF treatment of tumors.

NsPEFs and immune surveillance

Pre-clinical studies indicate the feasibility and general safety for
using nsPEF treatments for several types of cancer. While early studies
were carried out with a mouse melanoma model [3,4,72], this is not the
best disease model for clinical application for cancer treatment because
melanoma is a systemic and metastatic disease, while nsPEF ablation is
a localized treatment. More applicable cancers include squamous cell
carcinoma [54,76] and basal cell carcinoma [7,77]. These are generally
not metastatic, and are readily accessible and treatable malignancies
for nsPEFs.

In research that is ongoing and in need of further study, nsPEFs
may reverse evasion of immune surveillance in nsPEF treated mouse
ectopic Hepa1-6 HCC [71], and orthotopic N1-S1 HCC. In 6 of 8
tumors that were cleared of Hepa1-6 HCC tumors for 60 days, none of
the six grew new tumors for 49 days after being challenged with another
tumor cell injection in the opposite flank. In contrast, all 8 age-matched
naïve mice readily grew tumors. Similar results have also been observed
in a UV-induced murine melanoma study [72]. After treatment with
nsPEFs, challenge tumor cell injections resulted in slower growth of
tumors cleared by nsPEFs than in mice treated by surgically removing
tumors. This suggests that after treatment, the immune system might
have alerted to recognize primary tumor cells as foreign. Thus, nsPEF
treatment may induce immunogenic cell death, which has been shown
to occur more readily when cells die in response to some, but not all
apoptotic stimuli [73,74]. This suggests that successful treatment with
nsPEFs may induce a vaccine response in the treated host that would
prevent recurrence of tumors, which is a major problem in cancer
therapy.

Advantages of nsPEF Ablation For Cancer Treatment
So what advantages do nsPEFs provide over other cancer
treatments? First, nsPEFs target multiple cell death mechanisms. In
in vitro experiments with B16f10 melanoma, E4 SSC and Jurkat cell
models, as well as the ectopic models of melanoma and HCC, more than
one mechanism for cell death was present. Second, nsPEFs produce a
well-defined treatment zone, which is defined by a center active needle
and four surrounding ground electrode in a 5 needle array [75]. When
all tumor cells are placed within these treatment zone boundaries and
are exposed to electric field strength, above an ablation threshold for a
sufficient time, all tumor cells will die by more than one mechanism.
Third, as shown in Jurkat cells and N1-S1 HCC models in vitro, nsPEF
appears to target mitochondria, and the ΔΨm, especially when the
plasma membrane is permeabilized and calcium is present. Fourth,
nsPEFs can bypass cancer mutations when tumor cells are exposed
to an ablation electric field for an appropriate period of time. Tumor
cells that evade apoptosis by expressing mutation affecting the Fas and
J Nanomed Nanotechol
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Future Directions With nsPEF Treatment Of Cancer

We are presently finishing a series of studies using an orthotopic
rat N1-S1 HCC model that shows excellent results. Our future goals
are to treat larger HCC tumors with shorter treatment times. Also, we
have specific interests in ongoing research in the orthotopic model for
possible positive effects of nsPEFs, to enhance immune surveillance
after treatment. We are in pursuit to identify mechanisms that are
responsible for the absence of growth of a second challenge tumor
cell injection, after successful nsPEF treatment of the primary tumor
[71]. Other efforts are to develop applications of nsPEFs to include
minimally invasive, laparoscopic treatments with catheter electrodes,
guided by ultrasound using the rabbit VX2 HCC tumor model.
Because cancers are always treated with more than one therapy,
either in combination or in sequence, we have considered using low
non-toxic doses of chemotherapeutic agents, before or after treatment
with nsPEFs. We have recently demonstrated that nsPEFs and
gemcitabine act synergistically to effectively treat an oral squamous cell
carcinoma in vitro [78]. This would allow treatments of larger tumors
with lower electric fields.
We continue to be interested in mechanisms of nsPEF-induced
cell death, and the N1-S1 tumor cells exhibits some behaviors that are
different that previously observed. These tumor cells present a paradox.
We see relative high caspase activity in untreated cells in vitro [79],
that deceases with time and with increasing electric fields. However, in
vivo, we see active caspase-3 in populations of cells in tissue slices from
treated tumors. Nevertheless, as reported here and elsewhere [44,45],
the nsPEF target is a calcium-dependent decrease in ΔΨm in these cells.
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The State Of And The Future For Bioelectrics
There are growing numbers of investigators in Bioelectric Centers
around the World that are investigating all aspects of Bioelectrics,
included at the beginning of this review. For example, the Frank Reidy
Research Center for Bioelectrics at Old Dominion University now
includes 17 principle investigators, occupying about 28,000 square
feet in a new building that includes new state of the art animal facility
and state of the art diagnostic and investigational equipment and
instruments. There is now a Consortium for Bioelectrics, including
3 Centers in the US, 2 in France, 2 in Germany, and 1 each in Italy,
Slovenia and Japan. There are also other groups who are not part of
the Consortium working on Bioelectrics in the US, Germany, France,
Korea, Singapore, Japan and China. It is highly likely that the number
of investigators will continue to grow, and new applications will be
realized as Bioelectrics research continues to evolve.
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